Kevin Hay
9PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Feb 26, 2026
Real-World Outcomes of Axicabtagene Ciloleucel for Treatment of Relapsed or Refractory Large B-Cell Lymphoma in Canada.Christopher Lemieux, John Kuruvilla, Mona Shafey
|Nov 24, 2023
Hematopoietic Cell Transplantation Trends and Outcomes in Canada: A Registry-Based Cohort Study.Matthew D Seftel, Ivan Pasic, Gaganvir Parmar
|Jan 22, 2021
Efficacy and safety of CD22 chimeric antigen receptor (CAR) T cell therapy in patients with B cell malignancies: a protocol for a systematic review and meta-analysis.Komal Adeel, Nathan J Fergusson, Risa Shorr
|Jul 21, 2020
Building Canadian capacity for CAR-T cells in relapsed/refractory acute lymphoblastic leukaemia: a retrospective cohort study.Roy Khalife, Joshua Montroy, Emma J M Grigor
|Feb 21, 2019
The response to lymphodepletion impacts PFS in patients with aggressive non-Hodgkin lymphoma treated with CD19 CAR T cells.Alexandre V Hirayama, Jordan Gauthier, Kevin A Hay
Pageof 2
Frequent Collaborators
3 joint publications
Stanley R Riddell
3 joint publications
David G Maloney
3 joint publications
Cameron J Turtle
2 joint publications
Hans-Peter Kiem
2 joint publications
Ryan D Cassaday
2 joint publications
Jordan Gauthier
2 joint publications
Alexandre V Hirayama
2 joint publications
Brian G Till
2 joint publications
Aude G Chapuis
2 joint publications
Reed M Hawkins